223 related articles for article (PubMed ID: 10925984)
1. Clinical implications of TT virus superinfection in patients with chronic hepatitis C.
Watanabe H; Saito T; Kawamata O; Shao L; Aoki M; Terui Y; Mitsuhashi H; Matsuo T; Takeda Y; Saito K; Togashi H; Shinzawa H; Takahashi T
Am J Gastroenterol; 2000 Jul; 95(7):1776-80. PubMed ID: 10925984
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K
J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224
[TBL] [Abstract][Full Text] [Related]
3. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies].
Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B
Orv Hetil; 2004 May; 145(19):987-92. PubMed ID: 15181733
[TBL] [Abstract][Full Text] [Related]
4. Relationships between TT virus infection and hepatitis C virus response to interferon therapy in doubly infected patients.
Maggi F; Fornai C; Tempestini E; Andreoli E; Lanini L; Vatteroni ML; Pistello M; Marchi S; Antonelli G; Bendinelli M
J Biol Regul Homeost Agents; 2003; 17(2):176-82. PubMed ID: 14518719
[TBL] [Abstract][Full Text] [Related]
5. TT virus infection during chronic hepatitis C.
Trimoulet P; de Lédinghen V; Ekouevi D; Bernard PH; Merel P; Chêne G; Couzigou P; Fleury H
Am J Gastroenterol; 2000 Jul; 95(7):1765-9. PubMed ID: 10925982
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of TT virus infection in patients with chronic hepatitis C.
Zein NN; Arslan M; Li H; Charlton MR; Gross JB; Poterucha JJ; Therneau TM; Kolbert CP; Persing DH
Am J Gastroenterol; 1999 Oct; 94(10):3020-7. PubMed ID: 10520863
[TBL] [Abstract][Full Text] [Related]
7. Relationship of TT virus infection with prevalence of hepatitis C virus infection and elevated alanine aminotransferase levels.
Watanabe H; Shinzawa H; Shao L; Saito T; Takahashi T
J Med Virol; 1999 Jul; 58(3):235-8. PubMed ID: 10447418
[TBL] [Abstract][Full Text] [Related]
8. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
[TBL] [Abstract][Full Text] [Related]
9. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
[TBL] [Abstract][Full Text] [Related]
10. Effect of TT virus co-infection on interferon response in chronic hepatitis C patients.
Kawanaka M; Niiyama G; Mahmood S; Ifukube S; Yoshida N; Onishi H; Hanano S; Ito T; Yamada G
Liver; 2002 Aug; 22(4):351-5. PubMed ID: 12296969
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
[TBL] [Abstract][Full Text] [Related]
12. The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naïve chronic hepatitis C patients.
Dai CY; Yu ML; Chuang WL; Hou NJ; Hou C; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
Antiviral Res; 2002 Jan; 53(1):9-18. PubMed ID: 11684312
[TBL] [Abstract][Full Text] [Related]
13. TT virus infection in patients with hepatitis C: frequency, persistence, and sequence heterogeneity.
Irving WL; Ball JK; Berridge S; Curran R; Grabowska AM; Jameson CL; Neal KR; Ryder SD; Thomson BJ
J Infect Dis; 1999 Jul; 180(1):27-34. PubMed ID: 10353857
[TBL] [Abstract][Full Text] [Related]
14. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
16. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt.
Gad A; Tanaka E; Orii K; Kafumi T; Serwah AE; El-Sherif A; Nooman Z; Kiyosawa K
J Med Virol; 2000 Feb; 60(2):177-81. PubMed ID: 10596018
[TBL] [Abstract][Full Text] [Related]
18. A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. The Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Binelli G; Gelatti U; Portera G; Albertini A; Fasola M; Chiesa R; Nardi G
Hepatology; 1999 Jul; 30(1):294-9. PubMed ID: 10385670
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of TT virus infection in Italian dialysis patients.
Rivanera D; Lozzi MA; Idili C; Lilli D
Pathol Biol (Paris); 2009 Feb; 57(1):97-100. PubMed ID: 18842354
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibility of TT virus to interferon therapy].
Chayama K
Nihon Rinsho; 1999 Jun; 57(6):1390-4. PubMed ID: 10391005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
